Examples of using Comparator in English and their translations into Danish
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
In women who could not ovulate, GONAL-f produced ovulation in 84% of women compared with 91% for the Comparator.
The overall incidence of malignancies among all patients in the individual studies was similar between the basiliximab and the comparator treatment groups.
Apparent local reactions after intradermal administration were more frequent than after the comparator vaccine administered intramuscularly.
When making an assessment ofwhether harassment has taken place, a comparator does not need to be identified.
Tardive Dyskinesia In comparator studies of one year or less duration, olanzapine was associated with a statistically significant lower incidence of treatment emergent dyskinesia.
for example the Following example uses the Greater than comparator to Test the joining of two tuples From both tables.
three times a week) as a comparator.
compared with 84% of those receiving the comparator.
voltage comparator and voltage reference
compared with 51% of those receiving the comparator.
Relative Risk, comparator taken as reference;
those taking Prezista achieved lower viral loads than those taking the comparator protease inhibitors.
Fractures were observed in 2.6% of women taking pioglitazone compared to 1.7% of women treated with a comparator.
The Applicant was asked to justify the choice of this comparator and the clinical utility of Gadovist/ Gadograf with respect to diagnostic thinking,
What is new in version 1.1.2:Use CF comparator to sort indexed columns in SecondaryIndexManager.
However, in both studies, patients whose cancer was not affecting squamous cells had longer survival times if they received Alimta than if they received the comparator.
The difference in mortality was statistically significant in stratum 1(placebo comparator) but not in stratum 2 UFH comparator.
Valdoxan was seen to be more effective than placebo in the two studies where no active comparator was used.
Both EXUBERA and comparator treated subjects experienced declines in lung function over time during these trials Figures 2 and 3.
Treatment group differences(favouring comparator) in change from baseline of 0.034L in type 1